QLG-2198
- Generic Name
- QLG-2198
Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Qilu Pharmaceutical (Hainan) Co., Ltd.
- Target Recruit Count
- 194
- Registration Number
- NCT06446310
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳Jieyang People's Hospital, Jieyang, Guangdong, China
🇨🇳Shandong Provincial Hospital, Jinan, Shandong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath